Capturing circulating tumor cells of hepatocellular carcinoma

被引：53
|
作者：
Wu, Li-Jun [2 ]
Pan, Yi-Da [2 ]
Pei, Xiao-Yu [2 ]
Chen, Hong [3 ]
Nguyen, Samantha [4 ]
Kashyap, Akshay [4 ]
Liu, Jie [1 ,2 ]
Wu, Jian [2 ,4 ,5 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Digest Dis, Dept Digest Dis, Shanghai 210040, Peoples R China
[2] Fudan Univ, Inst Digest Dis, Shanghai 210040, Peoples R China
[3] Southeast Univ, Coll Med, Dept Gastroenterol & Hepatol, Nanjing 210009, Jiangsu, Peoples R China
[4] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA
[5] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA
来源：
CANCER LETTERS | 2012年 / 326卷 / 01期
关键词：
Circulating tumor cells; Hepatocellular carcinoma; Cancer stem cells; Tumor self-seeding; HCC thrombus formation in the portal vein; CANCER STEM-CELLS; LIVER-TRANSPLANTATION; IDENTIFICATION; BLOOD; METASTASIS; RECURRENCE; EXPRESSION; SIZE;
D O I：
10.1016/j.canlet.2012.07.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Early metastases of hepatocellular carcinoma (HCC) may be detected by the isolation of circulating tumor cells (CTCs) in the bloodstream. During the course of therapeutic attempts, monitoring CTC changes in patients with HCC is helpful for the efficacy assessment. Nevertheless, the markers used for the detection, such as alpha-feto protein, asialoglycoprotein receptor or epithelial cell adhesion molecule, CD133 or CD90, are not specific for HCC CTCs. In spite of these limitations, a timely determination of the existence of CTCs will be beneficial for the monitoring of distant metastases, the evaluation of therapeutic attempts, and the prediction of prognosis. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：17 / 22
页数：6
相关论文
共 50 条
  • [31] Correlation of Circulating Tumor Cells With Response to SBRT for Inoperable Hepatocellular Carcinoma
    Lee, V. H.
    Wong, V. C. L.
    Lam, C. T.
    Ho, P. P.
    Szeto, M. H.
    Ng, S. H.
    Li-Lung, M.
    Ko, J. M.
    Leung, T. W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E165 - E165
  • [32] Circulating tumor DNA detection in hepatocellular carcinoma
    Cabel, L.
    Proudhon, C.
    Buecher, B.
    Pierga, J. -Y.
    Bidard, F. -C.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (05) : 1094 - 1096
  • [33] A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma
    Court, Colin M.
    Hou, Shuang
    Winograd, Paul
    Segel, Nicholas H.
    Li, Qingyu Wilda
    Zhu, Yazhen
    Sadeghi, Saeed
    Finn, Richard S.
    Ganapathy, Ekambaram
    Song, Min
    French, Samuel W.
    Naini, Bita V.
    Sho, Shonan
    Kaldas, Fady M.
    Busuttil, Ronald W.
    Tomlinson, James S.
    Tseng, Hsian-Rong
    Agopian, Vatche G.
    [J]. LIVER TRANSPLANTATION, 2018, 24 (07) : 946 - 960
  • [34] Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells
    Court, Colin M.
    Hou, Shuang
    Liu, Lian
    Winograd, Paul
    DiPardo, Benjamin J.
    Liu, Sean X.
    Chen, Pin-Jung
    Zhu, Yazhen
    Smalley, Matthew
    Zhang, Ryan
    Sadeghi, Saeed
    Finn, Richard S.
    Kaldas, Fady M.
    Busuttil, Ronald W.
    Zhou, Xianghong J.
    Tseng, Hsian-Rong
    Tomlinson, James S.
    Graeber, Thomas G.
    Agopian, Vatche G.
    [J]. NPJ PRECISION ONCOLOGY, 2020, 4 (01)
  • [35] Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
    Yu, Jing
    Wang, Zhan
    Zhang, Hua
    Wang, Yi
    Li, Dong-Qing
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (43) : 7546 - 7562
  • [36] The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma
    Lina Zhao
    Zhifa Zheng
    Yunhe Liu
    Fei Liu
    Xiaoxin Li
    Zhihong Wu
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 6035 - 6048
  • [37] Effect of surgical liver resection on circulating tumor cells in patients with hepatocellular carcinoma
    Yu, Jing-jing
    Xiao, Wei
    Dong, Shui-lin
    Liang, Hui-fang
    Zhang, Zhi-wei
    Zhang, Bi-xiang
    Huang, Zhi-yong
    Chen, Yi-fa
    Zhang, Wan-guang
    Luo, Hong-ping
    Chen, Qian
    Chen, Xiao-ping
    [J]. BMC CANCER, 2018, 18
  • [38] Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma
    Jing Yu
    Zhan Wang
    Hua Zhang
    Yi Wang
    Dong-Qing Li
    [J]. World Journal of Gastroenterology, 2021, 27 (43) : 7546 - 7562
  • [39] Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells
    Colin M. Court
    Shuang Hou
    Lian Liu
    Paul Winograd
    Benjamin J. DiPardo
    Sean X. Liu
    Pin-Jung Chen
    Yazhen Zhu
    Matthew Smalley
    Ryan Zhang
    Saeed Sadeghi
    Richard S. Finn
    Fady M. Kaldas
    Ronald W. Busuttil
    Xianghong J. Zhou
    Hsian-Rong Tseng
    James S. Tomlinson
    Thomas G. Graeber
    Vatche G. Agopian
    [J]. npj Precision Oncology, 4
  • [40] Detection and characterization of circulating epithelial tumor cells in patients with hepatocellular carcinoma (HCC)
    Berger, T.
    Kaufmann, R.
    Clement, J. H.
    Eberhardt, J.
    Malessa, C.
    Settmacher, U.
    Hochhaus, A.
    Wagner, K.
    [J]. ONKOLOGIE, 2013, 36 : 66 - 66
12345